HRP20181746T1 - Trpc4 modulatori za uporabu u liječenju ili prevenciji bola - Google Patents

Trpc4 modulatori za uporabu u liječenju ili prevenciji bola

Info

Publication number
HRP20181746T1
HRP20181746T1 HRP20181746TT HRP20181746T HRP20181746T1 HR P20181746 T1 HRP20181746 T1 HR P20181746T1 HR P20181746T T HRP20181746T T HR P20181746TT HR P20181746 T HRP20181746 T HR P20181746T HR P20181746 T1 HRP20181746 T1 HR P20181746T1
Authority
HR
Croatia
Prior art keywords
trpc4
modulators
pain
prevention
treatment
Prior art date
Application number
HRP20181746TT
Other languages
English (en)
Inventor
Eric M. Ostertag
John Stuart Crawford
Original Assignee
Poseida Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poseida Therapeutics, Inc. filed Critical Poseida Therapeutics, Inc.
Publication of HRP20181746T1 publication Critical patent/HRP20181746T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
HRP20181746TT 2011-12-16 2018-10-24 Trpc4 modulatori za uporabu u liječenju ili prevenciji bola HRP20181746T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161576619P 2011-12-16 2011-12-16
EP12806318.7A EP2790687B1 (en) 2011-12-16 2012-12-14 Trpc4 modulators for use in the treatment or prevention of pain
PCT/US2012/069753 WO2013090722A1 (en) 2011-12-16 2012-12-14 Trpc4 modulators for use in the treatment or prevention of pain

Publications (1)

Publication Number Publication Date
HRP20181746T1 true HRP20181746T1 (hr) 2018-12-28

Family

ID=47430150

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181746TT HRP20181746T1 (hr) 2011-12-16 2018-10-24 Trpc4 modulatori za uporabu u liječenju ili prevenciji bola

Country Status (17)

Country Link
US (2) US10131634B2 (hr)
EP (2) EP3485889B1 (hr)
JP (3) JP2015500345A (hr)
AU (2) AU2012352083B2 (hr)
CA (1) CA2859283C (hr)
CY (1) CY1121293T1 (hr)
DK (1) DK2790687T3 (hr)
ES (1) ES2692546T3 (hr)
HR (1) HRP20181746T1 (hr)
HU (1) HUE041294T2 (hr)
LT (1) LT2790687T (hr)
PL (1) PL2790687T3 (hr)
PT (1) PT2790687T (hr)
RS (1) RS57919B1 (hr)
SI (1) SI2790687T1 (hr)
TR (1) TR201815535T4 (hr)
WO (1) WO2013090722A1 (hr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2692546T3 (es) * 2011-12-16 2018-12-04 Poseida Therapeutics, Inc. Moduladores TRPC4 para usar en el tratamiento o la prevención del dolor
CN114096247B (zh) * 2019-04-11 2024-04-26 帝人制药株式会社 苯并咪唑衍生物及其用途

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
HU198036B (en) * 1983-08-22 1989-07-28 Hoechst Roussel Pharma Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them
US5506337A (en) 1985-03-15 1996-04-09 Antivirals Inc. Morpholino-subunit combinatorial library and method
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
IE66205B1 (en) 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
EP0586549B1 (en) 1991-05-10 2000-09-20 Genentech, Inc. Selecting ligand agonists and antagonists
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5288514A (en) 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5519134A (en) 1994-01-11 1996-05-21 Isis Pharmaceuticals, Inc. Pyrrolidine-containing monomers and oligomers
US5593853A (en) 1994-02-09 1997-01-14 Martek Corporation Generation and screening of synthetic drug libraries
US5539083A (en) 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5525735A (en) 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
US5549974A (en) 1994-06-23 1996-08-27 Affymax Technologies Nv Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
US5656449A (en) * 1995-03-06 1997-08-12 Molecular Probes, Inc. Neutral unsymmetrical cyanine dyes
EP2258726A1 (en) 1995-06-14 2010-12-08 The Regents of the University of California High affinity human antibodies to c-erbB-2
US5569588A (en) 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
US6188965B1 (en) 1997-04-11 2001-02-13 California Institute Of Technology Apparatus and method for automated protein design
US6403312B1 (en) 1998-10-16 2002-06-11 Xencor Protein design automatic for protein libraries
AU4802500A (en) * 1999-04-26 2000-11-10 Neurogen Corporation 2-aminoquinolinecarboxamides: neurokinin receptor ligands
US7375125B2 (en) 1999-08-04 2008-05-20 Ore Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
WO2001025277A1 (en) 1999-10-07 2001-04-12 Maxygen Aps Single-chain antagonist polypeptides
US20020072101A1 (en) 2000-01-21 2002-06-13 Gaughan Glen T. Novel human nucleic acid molecules and polypeptides encoding cation channels
WO2002044210A2 (en) 2000-12-01 2002-06-06 Bristol-Myers Squibb Company Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
AU2002316150A1 (en) 2001-05-22 2002-12-03 Bristol-Myers Squibb Company Polynucleotide encoding a novel trp channel family member, trp-plik2, and splice variants thereof
EP1427408A4 (en) * 2001-09-17 2005-10-26 Bristol Myers Squibb Co CYCLIC HYDROXAMINE ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND / OR TNF-a-CONVERTASE (TACE TNF-a-CONVERTING ENZYM)
PE20030701A1 (es) * 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
US20060194750A1 (en) * 2001-12-31 2006-08-31 Shuster Samuel J Methods and materials for modulating trpc4
US20050103029A1 (en) * 2002-01-15 2005-05-19 Keizou Kawahara Refrigerator having alarm device for alarming leakage of refrigerant
AU2003280654A1 (en) * 2002-10-31 2004-05-25 Kunihiro Tamura Golf club with which gravity rule is realized
US7256200B2 (en) 2003-02-10 2007-08-14 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Method and composition for potentiating an oplate analgesic
KR100561646B1 (ko) * 2003-10-23 2006-03-20 엘지.필립스 엘시디 주식회사 표시 소자용 박막 트랜지스터 기판 및 그 제조 방법
WO2005087742A1 (en) * 2004-03-08 2005-09-22 Exelixis, Inc. Metabolic kinase modulators and methods of use as pesticides
WO2005089206A2 (en) 2004-03-13 2005-09-29 Irm Llc Modulators of ion channel trpa1
DE102004017932A1 (de) * 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
US7524862B2 (en) 2004-04-14 2009-04-28 Boehringer Ingelheim International Gmbh Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
US20090325975A1 (en) 2005-07-15 2009-12-31 Helmut H Buschmann Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain
US20100016293A1 (en) 2006-07-03 2010-01-21 Rogier Adriaan Smits Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use
GB0615136D0 (en) 2006-07-29 2006-09-06 Univ Edinburgh Induction of analgesia in neuropathic pain
US20090131302A1 (en) 2007-04-11 2009-05-21 Pasricha Pankaj J Transient receptor potential vanilloid 1 and uses thereof
WO2009005602A2 (en) * 2007-06-27 2009-01-08 Dolby Laboratories Licensing Corporation Incremental construction of search tree with signature pointers for identification of multimedia content
CN101868443A (zh) 2007-09-20 2010-10-20 特拉维夫大学拉莫特有限公司 N-苯基邻氨基苯甲酸衍生物及其用途
US8084616B2 (en) 2007-10-24 2011-12-27 Abbott Laboratories TRPV1 antagonists
US7998993B2 (en) 2007-10-25 2011-08-16 Abbott Laboratories TRPV1 antagonists
KR20090047637A (ko) 2007-11-08 2009-05-13 재단법인서울대학교산학협력재단 커큐민 또는 이의 약학적으로 허용가능한 염을유효성분으로 함유하는 통증 예방 및 치료용 조성물
EA201000675A1 (ru) 2007-12-18 2011-06-30 Гленмарк Фармасьютикалс, С.А. Производные хромана как модуляторы trpv3
WO2009086303A2 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2010070804A1 (ja) * 2008-12-19 2010-06-24 パナソニック株式会社 画像検索装置及び画像検索方法
US20120148604A1 (en) 2009-08-20 2012-06-14 Transposagen Biopharmaceuticals, Inc. Trp inhibitors and uses thereof
US20120151609A1 (en) * 2009-08-20 2012-06-14 Ostertag Eric M Genetically Modified Rat Models for Pain
DE102009046649A1 (de) 2009-11-12 2011-05-19 Robert Bosch Gmbh Klimakompressor für ein Fahrzeug, Fahrzeug
AU2011253003B2 (en) 2010-05-13 2014-05-01 Amgen Inc. Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors
ES2692546T3 (es) * 2011-12-16 2018-12-04 Poseida Therapeutics, Inc. Moduladores TRPC4 para usar en el tratamiento o la prevención del dolor

Also Published As

Publication number Publication date
CA2859283C (en) 2021-03-09
EP3485889A1 (en) 2019-05-22
JP2015500345A (ja) 2015-01-05
CY1121293T1 (el) 2020-05-29
CA2859283A1 (en) 2013-06-20
DK2790687T3 (en) 2018-11-19
JP6858808B2 (ja) 2021-04-14
AU2012352083A1 (en) 2014-07-17
JP6534716B2 (ja) 2019-06-26
EP3485889B1 (en) 2023-09-06
JP2019135271A (ja) 2019-08-15
PT2790687T (pt) 2018-11-13
WO2013090722A1 (en) 2013-06-20
US20190135759A1 (en) 2019-05-09
AU2018202172A1 (en) 2018-04-26
EP2790687A1 (en) 2014-10-22
AU2018202172B2 (en) 2019-12-19
HUE041294T2 (hu) 2019-05-28
PL2790687T3 (pl) 2019-03-29
TR201815535T4 (tr) 2018-11-21
JP2018030875A (ja) 2018-03-01
RS57919B1 (sr) 2019-01-31
SI2790687T1 (sl) 2019-01-31
ES2692546T3 (es) 2018-12-04
US20140329856A1 (en) 2014-11-06
LT2790687T (lt) 2018-12-10
AU2012352083B2 (en) 2018-01-04
EP2790687B1 (en) 2018-08-29
US10131634B2 (en) 2018-11-20

Similar Documents

Publication Publication Date Title
IL261768B (en) Devices and methods for tissue treatment
EP2836270A4 (en) SYSTEMS AND METHODS RELATED TO THE TREATMENT OF BACK PAIN
EP2819703A4 (en) TREATMENT OF PAIN
IL229474A0 (en) Cannabinoids for use in the treatment of neuropathic pain
HK1215787A1 (zh) 用於治療疼痛的藥物組合
HK1207860A1 (en) 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders 2--5---2h--3-
EP2694079A4 (en) POLYMERS AND METHOD FOR PAIN TREATMENT
HK1210585A1 (en) Alpha-1-microglobulin for use in the treatment of mitochondria- related diseases -1
HK1203054A1 (en) Dinuceloside polyphosphates for the treatment of pain
ZA201501503B (en) Bio-inoculant and use thereof for treatment of effluents
ZA201408055B (en) Compositions and methods for the treatment of local pain
HRP20181761T1 (hr) Novi pripravak alfentanila za liječenje akutne boli
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
HRP20181746T1 (hr) Trpc4 modulatori za uporabu u liječenju ili prevenciji bola
HK1214771A1 (zh) 用於治療皮膚病的製劑
LT2863932T (lt) Kompozicija, skirta naudoti limfedemos gydymui
AU2012900796A0 (en) Pain treatment
ZA201303790B (en) Formulation useful for treating pain and/or inflammation
GB201013068D0 (en) Liquid treatment
AU2012903356A0 (en) Improvements in Medical Treatment